Jørn Herrstedt

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt et al. · New England Journal of Medicine · 2016 · 2.5K citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

Jean Klášterský, Julien de Naurois, K. V. I. Rolston et al. · Annals of Oncology · 2016 · 750 citations · Full text

Pharmacy, Infectious Diseases, Internal Medicine +8

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

Fausto Roila, Alex Molassiotis, Jørn Herrstedt et al. · Annals of Oncology · 2016 · 580 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Bone health in cancer patients: ESMO Clinical Practice Guidelines

Robert E. Coleman, Jean‐Jacques Body, Matti Aapro et al. · Annals of Oncology · 2014 · 564 citations · Full text

Medicine, Oncology, Orthopedic Surgery +16

Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment

Brigitte Bloechl‐Daum, Robert Deuson, Panagiotis Mavros et al. · Journal of Clinical Oncology · 2006 · 505 citations

Medicine, Oncology, Pharmacology +17